2020's IPO par­ty con­tin­ues with four new Nas­daq en­trants, in­clud­ing Cov­il­lion­aire Carl Hansen's Ab­Cellera

Three more com­pa­nies are mak­ing their Wall Street de­buts Fri­day as the in­dus­try’s record-break­ing IPO year nears a con­clu­sion, with two mas­sive rais­es in the group — in­clud­ing the newest Cov­il­lion­aire’s out­fit.

The biotechs Ab­Cellera, 4D Mol­e­c­u­lar Ther­a­peu­tics and Nanobi­otix, as well as biosim­u­la­tion com­pa­ny Cer­tara, all priced late Thurs­day. Cer­tara raised the most of the bunch at a whop­ping $668 mil­lion, while Carl Hansen’s Ab­Cellera neared the half-bil­lion mark at $483 mil­lion. 4DMT raised $193.2 mil­lion in its sec­ond IPO go-around, and Nanobi­otix fol­lowed up with a $99 mil­lion raise of their own.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.